Principal Financial Group Inc. Purchases 3,292 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)

Principal Financial Group Inc. increased its holdings in MiMedx Group, Inc. (NASDAQ:MDXG) by 6.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,495 shares of the company’s stock after purchasing an additional 3,292 shares during the period. Principal Financial Group Inc.’s holdings in MiMedx Group were worth $328,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Paradigm Capital Management Inc. NY increased its stake in MiMedx Group by 6.6% during the second quarter. Paradigm Capital Management Inc. NY now owns 4,167,200 shares of the company’s stock worth $28,879,000 after acquiring an additional 258,700 shares during the last quarter. Geode Capital Management LLC increased its position in MiMedx Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,794,358 shares of the company’s stock valued at $16,518,000 after purchasing an additional 44,254 shares during the period. Charles Schwab Investment Management Inc. raised its stake in MiMedx Group by 6.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,435,397 shares of the company’s stock worth $8,483,000 after buying an additional 92,726 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in MiMedx Group by 47.0% during the second quarter. Dimensional Fund Advisors LP now owns 1,292,822 shares of the company’s stock valued at $8,958,000 after purchasing an additional 413,443 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in MiMedx Group by 299.9% during the third quarter. Harbor Capital Advisors Inc. now owns 1,027,738 shares of the company’s stock valued at $6,074,000 after acquiring an additional 770,744 shares during the last quarter. Institutional investors own 79.15% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $12.00.

MiMedx Group Stock Down 3.0 %

NASDAQ:MDXG opened at $8.91 on Tuesday. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. MiMedx Group, Inc. has a twelve month low of $5.47 and a twelve month high of $10.14. The company has a market cap of $1.31 billion, a PE ratio of 16.20 and a beta of 1.96. The company’s 50 day moving average is $8.79 and its two-hundred day moving average is $7.27.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.